US Fertility Supplement Marketers Don’t Deliver

FDA and FTC jointly warn five marketers of supplements with claims to treat fertility and other reproductive disorders. The unapproved and misbranded drugs could harm consumers and deter them from seeking effective treatments.

One day US regulators are noting an unapproved OTC contraceptive, the next they’re warning companies making unsubstantiated fertility claims for their products.

The Food and Drug Administration and the Federal Trade Commission jointly warned five marketers products labeled as dietary supplements about using claims “their products

More from Compliance

More from Policy & Regulation